BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
ATOH1 |
ATOH1, ATH1: Protein atonal homolog 1 |
0.265 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
HTR7 |
HTR7: 5-hydroxytryptamine receptor 7 |
0.265 |
Evidence |
|
GPR81 |
GPR81, GPR104, FKSG80: Probable G-protein coupled receptor 81 |
GNAI2 |
Galphai2 protein |
0.265 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
OXER1 |
OXER1, GPR170, TG1019: Oxoeicosanoid receptor 1 |
0.265 |
Evidence |
|
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
GPR78 |
GPR78, UNQ5925/PRO19818: Probable G-protein coupled receptor 78 |
0.265 |
Evidence |
|
TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
TNFRSF18 |
TNFRSF18, AITR, UNQ319/PRO364, GITR: Tumor necrosis factor receptor superfamily |
0.265 |
Evidence |
|
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
OXER1 |
OXER1, GPR170, TG1019: Oxoeicosanoid receptor 1 |
0.265 |
Evidence |
|
SLC4A11 |
SLC4A11, BTR1: Sodium bicarbonate transporter-like protein 11 |
CA14 |
CA14, UNQ690/PRO1335: Carbonic anhydrase 14 precursor |
0.265 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
NTSR1 |
NTSR1, NTRR: Neurotensin receptor type 1 |
0.265 |
Evidence |
|
NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
GPR31 |
GPR31: Probable G-protein coupled receptor 31 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.265 |
Evidence |
|
KCNH6 |
KCNH6, ERG2, HERG2: Potassium voltage-gated channel subfamily H member 6 |
SCN5A |
SCN5A: Sodium channel protein type 5 subunit alpha |
0.265 |
Evidence |
|
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
OXGR1 |
OXGR1, GPR80, GPR99, P2RY15, P2Y15: 2-oxoglutarate receptor 1 |
0.265 |
Evidence |
|
SIM2 |
IPI00220895 |
NEUROD2 |
NEUROD2, NDRF: Neurogenic differentiation factor 2 |
0.265 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GPR119 |
GPR119: Probable G-protein coupled receptor 119 |
0.265 |
Evidence |
|
GABRA3 |
GABRA3: Gamma-aminobutyric acid receptor subunit alpha-3 precursor |
GABRB2 |
GABRB2: Gamma-aminobutyric acid receptor subunit beta-2 precursor |
0.265 |
Evidence |
|
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
0.265 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BAX |
BAX: Apoptosis regulator BAX, membrane isoform alpha |
0.265 |
Evidence |
|
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
NMUR1 |
GPR66, NMUR1: Neuromedin-U receptor 1 |
0.265 |
Evidence |
|
C6orf11 |
FP221, WDR46, BING4, C6orf11: WD repeat-containing protein 46 |
QARS |
QARS: Glutaminyl-tRNA synthetase |
0.265 |
Evidence |
|
PYCARD |
PYCARD, ASC, CARD5, TMS1: Apoptosis-associated speck-like protein containing a C |
AIM2 |
AIM2: AIM2 protein |
0.265 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
NEUROD2 |
NEUROD2, NDRF: Neurogenic differentiation factor 2 |
0.265 |
Evidence |
|
NCOA2 |
NCOA2, TIF2: Nuclear receptor coactivator 2 |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
APOA1 |
APOA1: Apolipoprotein A-I precursor |
BPIL3 |
BPIL3: Bactericidal/permeability-increasing protein-like 3 precursor |
0.265 |
Evidence |
|
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
MRGPRX3 |
MRGPRX3, MRGX3, SNSR1, SNSR2: Mas-related G-protein coupled receptor member X3 |
0.265 |
Evidence |
|